1Djavan B, Fong YK, Remzi M, et al.New serum and urinary markers for prostate cancer detection in the new millennium[ J]. Eur Urol,2004,46 ( Suppl) 3:25.
2Hernandez J, Thompson IM. Prostatespecific antigen: a review of the validation of the most commonly used cancer biomarker [ J ]. Cancer, 2004, 101(5) :894.
3Gretzer MB, Partin AW. PSA levels and the probability of prostate cancer on biopsy[J]. Eur Urol,2002,44 (Suppl 1):14.
4Denmeade SR, Isaacs JT. The role of prostate-specific antigen in the clinical evaluation of prostatic disease[ J]. BJU Int, 200d,93(Suppl 1):10.
5Gann PH, Hennekens CH, Stampfer MT. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer[J]. JAMA, 1995, 273(4) :289.
6Sokoloff MH, Yang X J, Fumo M, et al. Characterizing prostatic adenocarcinomas in men with a serum prostate spe-cific antigen level of < 4. 0 ng/ml [J].BJU Int, 2004, 93 (4) : 499.
7Tinzl M, Djavan B, Marberger M.uPM3 test, a new molecular assay detecting prostate cancer in urine samples,a new future perspective[J]. AUA Program Abstract, 2003,169(Suppl) : 121.
8Saad F, Aprikian AG, Dessureault J,et al. Multicenter study of the uPM3 test, a new molecular urine assay to detect prostate cancer[ J]. AUA Program Abstract, 2003,169(Suppl) : 121.
9Miller JC, Zhou H, Kwekel J, et al.Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers[J]. Proteomics, 2003, 3( 1 ): 56.
10Weir EG, Partin AW, Epstein JI. Correlation of serum prostate specific antigen and quantitative immunohistochemistry[J]. J Urol, 2000, 163(6) : 1739.
10Kennedy-Smith AG,Mckenzie JL,Owen MC. Prostate specific antigen inhibits immune responses in vitro:A potential role in prostate cancer[J].Journal of Urology,2002,(02):741-747.
